This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
O'Grady J et al. (2002) Tacrolimus versus microemulsified cyclosporin in liver transplantation: The TMC randomized controlled trial. Lancet 360:1119–1125
Fung JJ et al. (1996) The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg 183: 117–125
Levy G et al. (2006) 12-Month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transplant 12: 1464–1472
Barenguer M et al. (2007) Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis. Liver Transplant 13: 21–29
Larsen CP et al. (2005) Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 5: 443–453
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Khan, M., Tector, A. & Kwo, P. Tacrolimus or microemulsified ciclosporin for immunosuppression after liver transplantation?. Nat Rev Gastroenterol Hepatol 4, 424–425 (2007). https://doi.org/10.1038/ncpgasthep0874
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0874